ab106633 is predicted not to crossreact with other ELOVL proteins.
A 15 amino acid peptide near the amino terminus of Human ELOVL7 (NP_001098028).
Human liver tissue lysate; Human liver tissue
Shipped at 4°C. Store at 4°C (stable for up to 12 months).
Preservative: 0.02% Sodium Azide
Concentration information loading...
Immunogen affinity purified
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 20 µg/ml.
Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 33 kDa.
Use at an assay dependent concentration.
Condensing enzyme that catalyzes the synthesis of saturated and polyunsaturated very long chain fatty acids. Highest activity toward C18 acyl-CoAs, especially C18:3(n-3) acyl-CoAs.
Expressed in most tissues except heart and skeletal muscle.
Belongs to the ELO family.
The di-lysine motif may confer endoplasmic reticulum localization.
Endoplasmic reticulum membrane.
Information by UniProt
3-keto acyl-CoA synthase Elovl7 antibody
Elongation of very long chain fatty acids protein 7 antibody
Immunocytochemistry/ Immunofluorescence - Anti-ELOVL7 antibody (ab106633)
Immunofluorescence of ELOVL7 in Human liver tissue with ab106633 at 20 ug/mL.
Western blot - Anti-ELOVL7 antibody (ab106633)
Anti-ELOVL7 antibody (ab106633) at 1 µg/ml + Human liver tissue lysate at 15 µg
Predicted band size: 33 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ELOVL7 antibody (ab106633)
ab106633, at 5 µg/ml, staining ELOVL7 in paraffin embedded Human liver tissue by Immunohistochemsitry.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"